Home › Interstitial Lung Diseases › Indiana
Interstitial Lung Diseases clinical trials in Indiana
6 studies for Interstitial Lung Diseases are looking for participants at sites in Indiana.
Cities in Indiana
FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression
- Indiana University Health Enterprise Clinical Research Operation, Indianapolis
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07540988A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
- Indiana University, Indianapolis
RecruitingPhase 2
Ages 40 and older · All sexes · Updated Sep 4, 2026 · NCT06968845Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
- Indiana University Health Methodist Hospital, Indianapolis
- Community Health Network, Indianapolis
Recruiting
Ages 18 and older · All sexes · Updated Sep 2, 2026 · NCT06911632A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD
- St. Vincent Cardiovascular Research Institute, Indianapolis
RecruitingPhase 3
Ages 18 to 80 · All sexes · Updated Sep 2, 2026 · NCT07285655DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- Ascension St. Vincent, Indianapolis
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 26, 2026 · NCT06388421An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH
- Vincent Medical Group, Indianapolis
RecruitingObservational study
Ages 18 to 80 · All sexes · Updated Jun 26, 2026 · NCT06129240From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.